Sang A to sell out by public tender in July.

Published: 2001-06-04 06:58:00

Updated: 2001-06-04 06:58:00

The major creditors of Sang A pharmaceutical company such as the Korea Asset Management Corporation (KAMC) and the Korea Development Bank (KDB) had a creditor's meeting last month and appointed Woobang, a law firm and KPMG.FSI, an M&A consulting company, as their financial counselors. They decide...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK